Cairo Pharmaceuticals results, Fiscal year 2026
Net profit, assets, equity and cash flow for Fiscal year 2026, against the same period a year earlier, from the published financial statements. fiscal year starts in July. The figures cover the 12 months to 30 June 2026; the comparison is with the same months a year earlier, from the same disclosure.
In short
- Cairo Pharmaceuticals's net profit for Fiscal year 2026 was about 553 million EGP, up +24.5% from 444 million EGP in Fiscal year 2025.
Key lines against the same period a year earlier
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. The figures cover the 12 months to 30 June 2026; the comparison is with the same months a year earlier, from the same disclosure.
Cairo Pharmaceuticals's Q1 2027 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy